Navigation Links
OHSU research team joins elite consortium dedicated to curing type 1 diabetes
Date:9/15/2010

PORTLAND, Ore. -- Oregon Health & Science University's Markus Grompe, M.D., will lead a multi-center team of scientists selected to participate in the prestigious Beta Cell Biology Consortium (BCBC). Funded by the National Institute of Diabetes and Digestive and Kidney Diseases, the consortium's long-term goal is to develop a cell-based therapy for insulin delivery in type 1 diabetes patients.

"The goal of our work is to produce abundant quantities of functional human insulin-producing beta cells that can be used for transplantation to cure patients with type 1 diabetes. Our group in particular is focused on novel sources for transplantable beta cell replacements," said Grompe, principal investigator and director of the Pap Family Pediatric Research Institute, OHSU Doernbecher Children's Hospital; and director of the Oregon Stem Cell Center at OHSU.

Type 1 diabetes, formerly called juvenile diabetes, is characterized by a lack of insulin that results from the destruction of the insulin-producing beta cells of the pancreas. Without insulin, the body cannot process the glucose it receives from food and requires for energy. People with type 1 diabetes must take insulin every day, either by injection or continuously through a pump. To ensure they are receiving the proper amount, they frequently test their blood-glucose levels, which requires multiple finger pricks throughout the day.

"It is our hope that through the work of this interactive consortium, we can eliminate the need for this painful, lifelong ritual," said Grompe.

Grompe is a nationally accomplished stem cell and gene therapy expert. His pioneering work on liver stem cells and liver regeneration medicine provided a natural segue to this line of research. Recent studies by Grompe, BCBC project co-investigator Philip Streeter, Ph.D., and others indicate adult liver cells can successfully be converted into insulin-producing beta cells through genetic reprogramming in a mouse model. However, it is not yet know which liver cells can best be transformed into beta cells, and existing methods for growing liver cells in tissue culture are not well developed, according to Grompe.

With the support of this and similar grants, Grompe and colleagues are working to determine which type of liver cell is most easily converted and perfecting their methods of growing them in tissue culture. In addition, they are exploring the potential for harvesting and manipulating cells from novel sources, including the gall bladder.

"We have found that human gall bladder cells, which are very similar to the cells within the liver, can be grown and expanded in tissue culture very easily. It is a very promising source of reprogrammable beta cells," explained Grompe, who also is a professor of pediatrics and molecular and medical genetics in the OHSU School of Medicine, OHSU Doernbecher Children's Hospital.


'/>"/>

Contact: Tamara Hargens-Bradley
hargenst@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... of Pittsburgh now have easier access to the robotic-assisted total-hip and partial-knee ... Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson Hospital recently started ...
(Date:3/29/2017)... ... 2017 , ... The Wharton School of the University of Pennsylvania is pleased ... a $10 million gift to establish the Ken Moelis and Julie Taffet Moelis ... a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional ...
(Date:3/29/2017)... ... 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint users learn ... on-premises installation of its Help System for SharePoint was at the farm level. Enterprises ... entire tenant. , The company recently released a modified version of the Help ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is the annual ... the Diabetes Risk Test to find out if they are at risk for developing ... light up the evening sky by programming the LAX pylons the color red. Downtown’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... first technology to directly address the resolution to globally reduce the harmful use ... patented compound of FDA and TTB approved ingredients that when infused into alcohol, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017  Maxor National Pharmacy Services, LLC ("Maxor"), ... has named Leah Bailey as General Counsel.  Bailey ... the company. With more than 13 years ... years focused on health care, Bailey joins the Maxor ... Prime, Bailey advised the PBM, Specialty, and Mail Order ...
(Date:3/29/2017)... 29, 2017 Varian Medical Systems (NYSE: ... the second quarter of fiscal year 2017 following the close ... release will be followed by a teleconference available to all ... a link to the conference call webcast will be available ... the teleconference call and replay: ...
(Date:3/29/2017)...  Spiral Therapeutics, Inc. today announced the signature ... for the worldwide exclusive rights to Bionure,s lead ... of otolaryngology for aggregate payments of up to ... provides Spiral with the option to license two ... Under the terms of the agreement, Spiral will ...
Breaking Medicine Technology: